If you wish to report an adverse event or product complaint, please call 1-800-LILLYRX(1-800-545-5979)
Humalog®
- Full Prescribing Information
Humalog® U-100 (insulin lispro injection)
100 units/mL - Full Prescribing Information
Humalog® U-200 (insulin lispro injection)
200 units/mL - Full Prescribing Information
Humalog® MIX50/50™ (50% insulin lispro protamine suspension 50% insulin lispro injection [rDNA origin])
100 units/mL - Full Prescribing Information
Humalog® MIX75/25™ (75% insulin lispro protamine suspension 25% insulin lispro injection [rDNA origin])
100 units/mL
This information is provided in response to your request. Resources may contain information about doses, uses, formulations and populations different from product labeling. See Prescribing Information above, if applicable.
HUMALOG® (insulin lispro): Changing From Other Mealtime Insulin Products
Dose adjustment may be needed when transitioning from another insulin to Humalog.
Dose adjustment may be needed when transitioning from another insulin to IL-100.1
The patient's GC or predisposition to hypoglycemia or hyperglycemia may be affected by changes in insulin
strength
manufacturer
type
injection site, or
method of administration.1
Any changes to insulin regimen for a patient with DM should be made cautiously and under close medical supervision and the frequency of BG monitoring should be increased.1
Enclosed Prescribing Information
HUMALOG® (insulin lispro injection), for subcutaneous or intravenous use, Lilly
1. Humalog [package insert]. Indianapolis, IN: Eli Lilly and Company; 2019.
Glossary
BG = blood glucose
DM = diabetes mellitus
GC = glucose control
IL-100 = Humalog® (insulin lispro injection) 100 units/mL
Date of Last Review: December 13, 2019
Contact Lilly
Call Us
If you need information about a Lilly product or want to report an Adverse Event or Product Complaint, you may call us.
Available Mon - Fri, 9am - 7pm EST